$TMO · Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. filed its quarterly report on Form 10-Q for the fiscal period ended September 26, 2026. The filing contains the company’s unaudited financial statements and related notes for the three and nine months then ended, as required by the SEC. This is a routine periodic disclosure of financial position, results of operations, and cash flows.

The provided excerpt consists largely of XBRL tagging data rather than narrative discussion, so specific figures for revenue, net income, or other operational metrics are not visible in this text. The tagged data does include references to multiple outstanding senior notes with maturity dates ranging from 2026 through 2049, indicating the company’s long-term debt obligations as of the reporting date.

Because the excerpt does not include the management discussion or summarized financial highlights, the main event of the filing cannot be identified beyond the fact that Thermo Fisher submitted its standard third-quarter 10-Q report. No further conclusions should be drawn from the limited text available.